Skip to main content
SpringerLink
Log in

Update 2016

Vorhofflimmern — neue Aspekte bei der Therapie

Atrial fibrillation — Update 2016

  • FORTBILDUNG_ÜBERSICHT
  • Published:
MMW - Fortschritte der Medizin Aims and scope

An Erratum to this article was published on 20 July 2016

Zusammenfassung

Oberstes Ziel der Therapie von Vorhofflimmern ist die Schlaganfall- und Embolieprophylaxe mit oraler Antikoagulation. Der operative Verschluss des linksatrialen Vorhofohrs kann dazu eine sinnvolle Alternative sein. Die Katheterablation, mittlerweile als „Second-line-Therapie“ etabliert, wird zunehmend auch „first line“ eingesetzt. Neue Behandlungsansätze rücken die Prävention struktureller Umbauvorgänge in den Mittelpunkt.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3
Abb. 4
Abb. 5

Literatur

  1. Go AS, Hylek EM, Phillips KA et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285:2370–5

    Article  CAS  PubMed  Google Scholar 

  2. Schnabel RB, Sullivan LM, Levy D et al. Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet. 2009;373:739–45

    Article  PubMed  PubMed Central  Google Scholar 

  3. Benjamin EJ, Levy D, Vaziri SM et al. Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart Study. JAMA. 1994;271:840–4

    Article  CAS  PubMed  Google Scholar 

  4. Miyasaka Y, Barnes ME, Gersh BJ et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation. 2006;114:119–25

    Article  PubMed  Google Scholar 

  5. Naccarelli GV, Varker H, Lin J, Schulman KL. Increasing prevalence of atrial fibrillation and flutter in the United States. Am J Cardiol. 2009;104:1534–9

    Article  PubMed  Google Scholar 

  6. Heeringa J, van der Kuip DA, Hofman A et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J. 2006;27:949–53

    Article  PubMed  Google Scholar 

  7. Goette A, Hammwöhner M, Bukowska A. Upstream therapy for atrial fibrillation. Herzschrittmacherther Elektrophysiol. 2014;25:33–40

    Article  PubMed  Google Scholar 

  8. Schotten U, Verheule S, Kirchhof P, Goette A. Pathophysiological mechanisms of atrial fibrillation: a translational appraisal. Physiol Rev. 2011;91:265–325

    Article  PubMed  Google Scholar 

  9. Camm AJ et al. Guidelines for the Management of atrial fibrillation. Eur Hear J. 2010;31:2369–2429.

    Article  Google Scholar 

  10. De Caterina R, Camm AJ. What is „valvular“ atrial fibrillation? A repraisal. Eur Heart J. 2014;35:3328–35

    Article  PubMed  Google Scholar 

  11. Eikelboom JW et al. Dabigatran versus warfarin in patients with mechanical heart valves. N Engl J Med. 2013;369:1206–14

    Article  CAS  PubMed  Google Scholar 

  12. Vanassche T et al. Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTUVE-A and AVERROES. Eur Heart J. 2014, epub ahead of print

  13. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146:857–67

    Article  PubMed  Google Scholar 

  14. Connolly SJ, Pogue J, Hart RG, Hohnloser SH, Pfeffer M, Chrolavicius S, Yusuf S. Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N Engl J Med. 2009;360:2066–78

    Article  PubMed  Google Scholar 

  15. Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, Mullin CM, Sick P; PROTECT AF Investigators. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet. 2009;374:534–42

    Article  CAS  PubMed  Google Scholar 

  16. Camm AJ et al. Focused Update Atrial Fibrillation Guidelines. Eur Heart J. 2012;33(21):2719–47

    Article  PubMed  Google Scholar 

  17. Meier B, Blaauw Y, Khattab AA, Lewalter T, Sievert H, Tondo C, Glikson M. Europace. 2014; 16(19):1397–416

    Article  PubMed  Google Scholar 

  18. Reinecke H, Brand E, Mesters R, Schäbitz WR, Fisher M, Pavenstädt H, Breithardt G. Dilemmas in the management of atrial fibrillation in chronic kidney disease. J Am Soc Nephrol. 2009;20(4):705–11

    Article  CAS  PubMed  Google Scholar 

  19. Kirchhof P, Andresen D, Bosch R et al.. Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial. Lancet. 2012;380/9838:238–46

    Article  Google Scholar 

  20. Defauw JJ, Guiraudon GM, van Hemel NM, Vermeulen FE, Kingma JH, de Bakker JM. Surgical therapy of paroxysmal atrial fibrillation with the corridor operation. Ann Thorac Surg. 1992;53:564–70

    Article  CAS  PubMed  Google Scholar 

  21. Swartz JF, Pellersel G, Silvers J et al. A catheter-based curative approach to atrial fibrillation in humans. Circulation. 1994;90(Pt II): I–335

    Google Scholar 

  22. Haissaguerre M, Jais P, Shah D et al. Spontaneous Initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998;339:659–66

    Article  CAS  PubMed  Google Scholar 

  23. Jais P, Haissaguerre M, Shah DC, Chouairi S, Gencel L, Honcini M, Clementy J. A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation. 1997;95:572–6

    Article  CAS  PubMed  Google Scholar 

  24. Nielsen JC, Johannessen A, Raatikainen M et al. Radiofrequency Ablation as Initial Therapy in Paroxysmal Atrial Fibrillation. New Engl J Med. 2012:367:1587–95

    Article  CAS  Google Scholar 

  25. Morillo C, Verma A, Kuck KH et al. Radiofrequency Ablation vs Antiarrhythmic Drugs as First-Line Treatment of Symptomatic Atrial Fibrillation: (RAAFT 2): A randomized trial. Heart Rhythm Society 2012 Scientific Sessions; May 11, 2012; Boston, MA. Abstract LB02-1

Download references

Author information

Authors and Affiliations

  1. Klinik für Kardiologie und Internistische Intensivmedizin, Peter Osypka Herzzentrum, Kliniken Dr. Müller, Am Isarkanal 36, D-81379, München, Deutschland

    Thorsten Lewalter

Authors
  1. Thorsten Lewalter
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thorsten Lewalter.

Additional information

The article is part of a supplement not sponsored by the industry.

Interessenkonflikt

Der Autor erklärt, dass er sich bei der Erstellung des Beitrages von keinen wirtschaftlichen Interessen leiten ließ. Er legt folgende potenzielle Interessenkonflikte offen: keine.

Der Verlag erklärt, dass die inhaltliche Qualität des Beitrags von zwei unabhängigen Gutachtern geprüft wurde. Werbung in dieser Zeitschriftenausgabe hat keinen Bezug zur CME-Fortbildung. Der Verlag garantiert, dass die CME-Fortbildung sowie die CME-Fragen frei sind von werblichen Aussagen und keinerlei Produktempfehlungen enthalten. Dies gilt insbesondere für Präparate, die zur Therapie des dargestellten Krankheitsbildes geeignet sind.

An erratum for this article can be found at http://dx.doi.org/10.1007/s15006-016-7662-x

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lewalter, T. Vorhofflimmern — neue Aspekte bei der Therapie. MMW - Fortschritte der Medizin 158 (Suppl 1), 20–28 (2016). https://doi.org/10.1007/s15006-016-7654-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15006-016-7654-x

Keywords

Search

Navigation